PATENT CLAIM ANALYSIS

Application Number: 16010412
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "010900"]

Abstract:
The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network comprises levan.

Claim (Index 41):
A pharmaceutical composition prepared by a process comprising at least a step of sublimating a solvent from a liquid preparation that comprises:\n (a) at least one matrix-forming agent that is levan to form an open matrix network; and (b) at least one pharmaceutically active ingredient, wherein the composition is an orodispersible pharmaceutical dosage form.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13636758', '13952084', '13638121', '14343285', '15881123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.761753786712692
- 35 USC 102 Novelty (BERT): 0.5925263028503662
- Combined Prediction Score: 0.7448310383264594
- Mean Citation Score: 423.055568
- Max Citation Score: 508.43652
- Similarity Product: 436.59870126239775

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test